CME Group Inc [CME] stock is trading at $212.00, up 1.06%. An important factor to consider is whether the stock is rising or falling in short-term value. The CME shares have lost -0.01% over the last week, with a monthly amount drifted -2.20%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 9, April 2024, CME Group Micro U.S. Treasury Futures Surpass 100,000 Contracts Traded. In a post published today on Yahoo Finance, CME Group, the world’s leading derivatives marketplace, today announced that trading in its new Micro U.S. Treasury futures has surpassed 100,000 contracts since launching just two weeks ago on March 25.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on January 08, 2024, when Barclays downgraded its rating to a Equal Weight and also revised its price target to $222 from $244. Previously, Goldman downgraded its rating to Sell on January 03, 2024, and kept the price target unchanged to $195. On September 06, 2023, upgrade upgraded it’s rating to Neutral and revised its price target to $204 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $215 on June 28, 2023. Credit Suisse upgraded its rating to a Outperform but $191 remained the price target by the analyst firm on January 05, 2023. Deutsche Bank upgraded its rating to Buy for this stock on October 12, 2022, and downed its price target to $200. In a note dated October 12, 2022, Citigroup initiated an Buy rating and provided a target price of $220 on this stock.
CME Group Inc [CME] stock has fluctuated between $171.43 and $222.63 over the past year. Currently, Wall Street analysts expect the stock to reach $218 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $212.00 at the most recent close of the market. An investor can expect a potential return of 2.83% based on the average CME price forecast.
Analyzing the CME fundamentals
CME Group Inc [NASDAQ:CME] reported sales of 5.58B for the trailing twelve months, which represents a growth of 19.17%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.62%, Pretax Profit Margin comes in at 0.74%, and Net Profit Margin reading is 0.58%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.12 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 209.96 points at the first support level, and at 207.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 213.70, and for the 2nd resistance point, it is at 215.41.
CME Group Inc [CME] reported earnings per share of $2.37 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $2.28/share, meaning a difference of $0.09 and a surprise factor of 3.90%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $2.25 per share as compared to estimates of $2.22 per share, a difference of $0.03 representing a surprise of 1.40%.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 13.68, the price to book ratio is 2.85 and price to earnings (TTM) ratio is 23.93.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Mar 26 ’24 when 282.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Mar 26 ’24 to buy 12.0 shares. Meanwhile, Sr MD Global Head Equity & FX McCourt Timothy Francis sold 35.0 shares on Jan 31 ’24.
